Tern invests in companies, with proven technology, based in the UK but with global ambition.
Our management team has a strong track record of unlocking opportunities in the USA for UK companies.
We look for well-motivated teams who are building innovative high growth businesses, with revenue and IP, and which are harnessing software to create or disrupt markets.
We predominantly invest in software companies which develop commercial IoT security, enablement and analytics solutions for the healthcare and industrial sectors, where safety and regulatory compliance are important market requirements.
Unlike many of our peers, we invest in only a handful of companies in a given period. This means we have the time to be a committed and hands on partner, invariably taking an active position on the Board of our investments.
To ensure your business has the financial agility to grow and grab opportunities we’ll inject the necessary capital.
We support the leadership team in all areas of running a company including overall strategy, finance, HR, marketing, sales, legal and operations management. If one of our directors hasn’t got the skill set and experience needed then we’ll bring it in from our extensive network of influential, market-leading contacts.
With collective experience in the IT space amounting to 100 years touching over 50 businesses, we have an impressive network of connections that can help create new supply chains, build your team out or close deals. We specialise in providing UK IoT businesses with access to networks and potential partners in the USA.
We don’t have a checklist but generally our investments share features including:
Tern PLC
Gridiron
One Pancras Square
London, N1C 4AG
e info@ternplc.com
t 0203 807 0222
The approval and rollout of the multiple Covid-19 vaccines has been a bright spot in a year which saw the world plunged into an unprecedented uncertainty. However, the current vaccines each have specific criteria which must be met in order to make sure they are effective, which has meant that the supply chain has had to consider smart ways to ensure successful delivery.
The past year has taught us many things about the healthcare sector – not least the extraordinary impact of big data analytics. As healthcare researchers and clinicians have gathered more data about Covid-19, from the genomic sequence of individual variants of the virus, to the typical progression of symptoms among different demographics, to the effects of various interventions, so the global response to the pandemic has become more intelligent and more efficient.
© Tern PLC | Sitemap | Terms & Conditions | Privacy Policy
B2B website design by Axon Garside